Ozempic (semaglutide) and phentermine both reduce appetite, but they are very different drugs. Ozempic is a weekly injection approved for type 2 diabetes; phentermine is an inexpensive stimulant pill approved only for short-term weight loss. Some doctors prescribe them together off-label, but that combination has not been FDA-approved or well studied.
- Ozempic: a GLP-1 receptor agonist for adults with type 2 diabetes. It lowers blood sugar, reduces the risk of heart attack, stroke and cardiovascular death in people with diabetes and heart disease, and slows kidney decline in diabetic kidney disease. It is not FDA-approved for weight loss; Wegovy is the semaglutide product approved for that.
- Phentermine: a stimulant related to amphetamine, approved since 1959 for short-term use (a few weeks) alongside diet and exercise in adults with obesity. It is a Schedule IV controlled substance.
- Weight loss: semaglutide at weight-loss doses produces about 15% average weight loss. Phentermine alone typically produces around 5% beyond placebo over a few months.
- Taking them together: possible under close medical supervision, but there are few safety data, and both can cause side effects that add up, especially poor appetite, nausea, dehydration and a faster heart rate.
- Who should avoid phentermine: people with heart disease, uncontrolled high blood pressure, hyperthyroidism, glaucoma, a history of drug misuse, or who are pregnant or breastfeeding.
This is general information, not medical advice. Never combine weight-loss or diabetes medicines without your prescriber’s knowledge. Some of these drugs are also sold illegally online in unsafe forms.
Ozempic vs phentermine at a glance
| Ozempic (semaglutide) | Phentermine | |
|---|---|---|
| Drug class | GLP-1 receptor agonist | Sympathomimetic amine (stimulant) |
| How it’s taken | Weekly injection | Daily tablet or capsule |
| FDA-approved for | Type 2 diabetes; heart and kidney risk reduction in type 2 diabetes | Short-term weight loss in adults with obesity |
| Weight-loss approved version | Wegovy (semaglutide 2.4 mg) | Phentermine is itself approved for weight loss; also in Qsymia with topiramate |
| Controlled substance | No | Yes, Schedule IV |
| How long it’s used | Long term | Usually up to 12 weeks under the label; sometimes longer off-label |
| Average weight loss | About 15% at 2.4 mg (as Wegovy) | About 5% beyond placebo |
| Cost | Expensive brand-name drug | Inexpensive generic |
| Main concerns | Stomach side effects, pancreatitis, gallbladder disease, thyroid tumor warning | Raised heart rate and blood pressure, insomnia, misuse potential |
How each drug works
Ozempic
Semaglutide mimics GLP-1, a gut hormone released after eating. It boosts insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and acts on appetite centers in the brain. People feel full faster and longer. Because semaglutide lasts about a week in the body, one injection a week is enough.
Ozempic doses go up to 2 mg weekly. Wegovy, the same drug at 2.4 mg weekly (or 7.2 mg as Wegovy HD), is the version approved for weight management.
Phentermine
Phentermine stimulates the release of noradrenaline (norepinephrine) and, to a lesser degree, dopamine and serotonin in the brain. This suppresses appetite and raises energy, much like a mild amphetamine. It became notorious in the 1990s as the “phen” in fen-phen. The heart valve damage linked to that combination was caused mainly by fenfluramine, which was withdrawn in 1997; phentermine stayed on the market.
Phentermine comes in 8 mg tablets (Lomaira), taken up to three times a day, and in 15 mg, 30 mg and 37.5 mg doses taken once daily, usually in the morning to avoid insomnia.
Effectiveness
Ozempic and semaglutide
- In people with type 2 diabetes, Ozempic 1 mg typically lowers HbA1c by about 1.5 to 1.8 points and weight by about 4 to 6 kg; the 2 mg dose lowers both a little more.
- At the weight-loss dose (Wegovy 2.4 mg), people without diabetes lost about 15% of their body weight on average over 68 weeks in the STEP 1 trial.
Phentermine
- Phentermine has been studied mostly in short trials. A typical result is about 3 to 8 kg of weight loss over 12 to 24 weeks, roughly 5% more than placebo.
- Qsymia (phentermine plus extended-release topiramate) is more effective, producing about 9% to 10% average weight loss at the top dose over a year in its main trials. It is approved for long-term use.
So, as single drugs, semaglutide produces roughly two to three times the weight loss of phentermine.
Can you take phentermine and Ozempic together?
It is possible, and some obesity specialists do prescribe them together, but here’s what to know:
- It’s off-label. The FDA has not approved this combination, and no large trial has tested its long-term safety.
- Small studies exist. Early real-world reports suggest some people lose extra weight when phentermine is added to a GLP-1 drug, but the data are limited.
- Side effects can stack. Both drugs reduce appetite, which can lead to eating too little, dizziness, dehydration and nutrient shortfalls. Phentermine raises heart rate and blood pressure, and semaglutide also raises resting heart rate by a few beats per minute.
- Constipation and dry mouth may be worse on the two together.
- Insurance and diabetes: Ozempic is covered for type 2 diabetes. If the goal is weight loss, Wegovy or Zepbound are the products approved for it.
If your doctor suggests combining them, expect closer follow-up, including blood pressure and heart rate checks.
A more common pattern
More often, doctors use phentermine instead of a GLP-1 drug when cost or access is a barrier, or for a short period before someone can start one. Some people also switch from phentermine to a GLP-1 drug when phentermine stops working or isn’t suitable for long-term use.
Side effects
Ozempic
- nausea, vomiting, diarrhea, constipation and stomach pain (most common)
- reduced appetite and indigestion
- low blood sugar when combined with insulin or sulfonylureas
- serious but less common: pancreatitis, gallbladder disease, kidney injury from dehydration, worsening diabetic retinopathy, severe stomach problems
- boxed warning: thyroid C-cell tumors seen in rodents
Phentermine
- dry mouth, unpleasant taste
- trouble sleeping
- restlessness, nervousness, irritability
- faster heart rate and palpitations
- raised blood pressure
- constipation or diarrhea
- dizziness and headache
- rare but serious: primary pulmonary hypertension, heart valve disease, psychosis and dependence
Stop phentermine and get medical help if you develop new shortness of breath, chest pain, fainting or swelling of the legs.
Who should not take phentermine
The phentermine label says not to use it if you have:
- a history of cardiovascular disease, such as coronary artery disease, stroke, arrhythmias, heart failure or uncontrolled high blood pressure
- an overactive thyroid (hyperthyroidism)
- glaucoma
- agitation or a history of drug misuse
- taken an MAO inhibitor in the past 14 days
- pregnancy or breastfeeding
- an allergy to sympathomimetic amines
Combining phentermine with other weight-loss drugs is not recommended on its label, which is one reason doctors are cautious about pairing it with a GLP-1 drug.
Who should not take Ozempic
- people with a personal or family history of medullary thyroid carcinoma or MEN 2
- people with a past serious allergic reaction to semaglutide
- people with type 1 diabetes (it is not a substitute for insulin)
- pregnancy: stop at least 2 months before a planned pregnancy because of its long half-life
Cost and access
- Phentermine is generic and usually costs little, though it requires an in-person prescription in many states because it is a controlled substance.
- Ozempic is costly at list price. Insurers generally cover it only for type 2 diabetes.
- Beware of online sellers. The FDA has warned about counterfeit and unapproved “semaglutide” products and compounded versions with dosing errors. Get any GLP-1 drug from a licensed pharmacy with a valid prescription.
Which is right for you?
| Situation | More suitable option |
|---|---|
| Type 2 diabetes | Ozempic (or another diabetes drug) |
| Obesity, long-term treatment wanted | Wegovy or Zepbound, rather than Ozempic or phentermine alone |
| Obesity, cost is the main barrier | Phentermine short term, or generic liraglutide (Saxenda) |
| Heart disease or high blood pressure | Avoid phentermine; a GLP-1 drug may be more suitable |
| History of stimulant misuse | Avoid phentermine |
| Already on a GLP-1 drug with a weight plateau | Discuss options with your doctor; adding phentermine is off-label |
Frequently asked questions
Can you take phentermine with Ozempic?
Some doctors prescribe them together off-label, but the combination is not FDA-approved and has limited safety data. Side effects such as poor appetite, dehydration, constipation and a faster heart rate can add up, so it should only be done under close medical supervision.
Which works better for weight loss, Ozempic or phentermine?
Semaglutide produces much more weight loss: about 15% on average at the 2.4 mg weight-loss dose (Wegovy), compared with roughly 5% beyond placebo for phentermine alone.
Is Ozempic approved for weight loss?
No. Ozempic is approved for type 2 diabetes. The same drug at a higher dose, Wegovy, is the semaglutide product approved for weight management.
How long can you take phentermine?
The label approves it for short-term use, typically up to 12 weeks. Some doctors prescribe it longer off-label with monitoring. Qsymia, which combines phentermine with topiramate, is approved for long-term use.
Is phentermine safe for the heart?
Phentermine raises heart rate and blood pressure and should not be used by people with heart disease or uncontrolled high blood pressure. Rarely it has been linked to pulmonary hypertension and heart valve problems.
Should I switch from phentermine to Ozempic?
If you have type 2 diabetes or need long-term weight management, a GLP-1 drug may be more suitable. For weight management without diabetes, Wegovy or Zepbound are the approved options. Discuss with your doctor.
References
- DailyMed. OZEMPIC (semaglutide) injection label
- DailyMed. Phentermine hydrochloride tablets label
- FDA. WEGOVY (semaglutide) prescribing information, revised 2026
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002
- Gadde KM, et al. Effects of low-dose, controlled-release phentermine plus topiramate on weight and associated comorbidities (CONQUER). Lancet. 2011;377:1341-1352
- FDA. FDA’s concerns with unapproved GLP-1 drugs used for weight loss
Try our interactive tool: GLP-1 weight loss drug comparison tool
Compare Zepbound, Wegovy, the Wegovy pill, Foundayo and Saxenda side by side.
About this article
Written by the Health Linear Editorial Team from primary sources such as FDA prescribing information, DailyMed, NIH and peer-reviewed studies, which are linked in the article. Last updated October 30, 2026.
Read our editorial process and medical disclaimer. Spotted an error? Tell us and we will correct it.